Literature DB >> 2854262

Phencyclidine receptors and N-methyl-D-aspartate antagonism: electrophysiologic data correlates with known behaviours.

D Martin1, D Lodge.   

Abstract

Using cortical wedges and isolated frog spinal cords, the potency of a series of psychoactive phencyclidine (PCP) and sigma receptor ligands as antagonists of N-methyl-D-aspartate (NMDA) has been compared with their potency in neurochemical and behavioural studies. Phencyclidine receptor, but not sigma or kappa, ligands were selective antagonists of NMDA on both preparations. Combination studies suggested that dissociative anaesthetics and sigma benzomorphans act at the same site. The relative potencies of the drugs as NMDA antagonists correlated well with their potency in PCP receptor binding studies in vitro and in PCP discrimination studies in vivo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2854262     DOI: 10.1016/0091-3057(88)90346-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  9 in total

Review 1.  Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators.

Authors:  Daniel T Monaghan; Mark W Irvine; Blaise Mathias Costa; Guangyu Fang; David E Jane
Journal:  Neurochem Int       Date:  2012-01-17       Impact factor: 3.921

Review 2.  NAAG, NMDA receptor and psychosis.

Authors:  Richard Bergeron; Joseph T Coyle
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

3.  A rapid method for evaluating the behavioral effects of phencyclidine-like dissociative anesthetics in mice.

Authors:  G E Evoniuk; R P Hertzman; P Skolnick
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 4.  Drug interactions with patient-controlled analgesia.

Authors:  Jorn Lotsch; Carsten Skarke; Irmgard Tegeder; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 5.  Current hypotheses on sigma receptors and their physiological role: possible implications in psychiatry.

Authors:  G Debonnel
Journal:  J Psychiatry Neurosci       Date:  1993-07       Impact factor: 6.186

Review 6.  Ketamine and phencyclidine: the good, the bad and the unexpected.

Authors:  D Lodge; M S Mercier
Journal:  Br J Pharmacol       Date:  2015-07-28       Impact factor: 8.739

7.  Social memory in mice: disruption with an NMDA antagonist and attenuation with antipsychotic drugs.

Authors:  Xue-Min Gao; Gregory I Elmer; Beverley Adams-Huet; Carol A Tamminga
Journal:  Pharmacol Biochem Behav       Date:  2008-12-10       Impact factor: 3.533

8.  Ketamine-Based Anesthetic Protocols and Evoked Potential Monitoring: A Risk/Benefit Overview.

Authors:  Nicoleta Stoicea; Gregory Versteeg; Diana Florescu; Nicholas Joseph; Juan Fiorda-Diaz; Víctor Navarrete; Sergio D Bergese
Journal:  Front Neurosci       Date:  2016-02-16       Impact factor: 4.677

9.  Recapitulation of Neuropsychiatric Behavioral Features in Mice Using Acute Low-dose MK-801 Administration.

Authors:  Darine Froy N Mabunga; Donghyun Park; Onjeon Ryu; Schley T Valencia; Keremkleroo Jym L Adil; Seonmin Kim; Kyoung Ja Kwon; Chan Young Shin; Se Jin Jeon
Journal:  Exp Neurobiol       Date:  2019-12-31       Impact factor: 3.261

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.